FibroGen
FGEN
$11.62
Share price
-0.77%
Change (1 day)
-60.06%
Change (1 year)
Market capitalization of FibroGen (FGEN)
Market cap: $1.08 Billion
As of June 2022 FibroGen has a market cap of $1.08 Billion. This makes FibroGen the world's 4244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of FibroGen from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.08 B | -17.07% |
| 2021 | $1.30 B | -61.27% |
| 2020 | $3.37 B | -10.21% |
| 2019 | $3.75 B | -4.91% |
| 2018 | $3.95 B | 1.48% |
| 2017 | $3.89 B | 188.26% |
| 2016 | $1.35 B | -28.44% |
| 2015 | $1.88 B | 17% |
| 2014 | $1.61 B |
End of Day market cap according to different sources
On Jun 24th, 2022 the market cap of FibroGen was reported to be:
$1.08 Billion
$1.08 Billion
$1.07 Billion
$1.08 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $30.46 B | 2,710.25% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 908.34% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $0.10 B | -90.03% | 🇺🇸 USA |